As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 Skilled Nursing/Transitional Care facilities, (ii) 64 Senior Housing communities (ÂSenior Housing - LeasedÂ), (iii) 47 Senior Housing communities operated by third-party property managers pursuant to property management agreements (ÂSenior Housing - ManagedÂ) and (iv) 27 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a direct financing lease, 19 investments in loans receivable (consisting of (i) one mortgage loan, (ii) one construction loan and (iii) 17 other loans), six preferred equity investments and one investment in an unconsolidated joint venture that owns 158 Senior Housing - Managed communities. As of September 30, 2020, Sabra's real estate properties held for investment included 42,378 beds/units and its unconsolidated joint venture included 7,056 beds/units, spread across the United States and Canada.
IPO Year:
Exchange: NASDAQ
Website: sabrahealth.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/17/2025 | Buy → Hold | Truist | |
| 1/7/2025 | $20.00 | Mkt Perform → Mkt Outperform | JMP Securities |
| 12/5/2024 | $20.00 | Outperform → Neutral | Mizuho |
| 10/1/2024 | $16.00 → $20.00 | Equal Weight → Overweight | Wells Fargo |
| 9/13/2024 | $17.00 → $20.00 | Neutral → Buy | Citigroup |
| 1/30/2024 | $21.00 | Buy | Deutsche Bank |
| 10/17/2023 | $16.00 | Outperform → Market Perform | BMO Capital Markets |
| 10/16/2023 | $13.00 → $15.00 | Underweight → Equal Weight | Wells Fargo |
| 10/10/2023 | $14.00 → $16.00 | Neutral → Buy | BofA Securities |
| 10/3/2023 | $16.00 | Outperform | Wedbush |
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
8-K - Sabra Health Care REIT, Inc. (0001492298) (Filer)
10-Q - Sabra Health Care REIT, Inc. (0001492298) (Filer)
424B5 - Sabra Health Care REIT, Inc. (0001492298) (Filer)
10-Q - Sabra Health Care REIT, Inc. (0001492298) (Filer)
8-K - Sabra Health Care REIT, Inc. (0001492298) (Filer)
8-K - Sabra Health Care REIT, Inc. (0001492298) (Filer)
10-Q - Sabra Health Care REIT, Inc. (0001492298) (Filer)
8-K - Sabra Health Care REIT, Inc. (0001492298) (Filer)
ARS - Sabra Health Care REIT, Inc. (0001492298) (Filer)
DEFA14A - Sabra Health Care REIT, Inc. (0001492298) (Filer)
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Darrin Smith, the company's Executive Vice President of Investments, and Lukas Hartwich, the company's Senior Vice President of Finance, will attend Nareit's REITworld 2024 Annual Conference on November 19-20, 2024 at the Wynn Las Vegas in Las Vegas, Nevada. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the third quarter of 2024. THIRD QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the third quarter of 2024 were as follows: Net Income: $0.13 FFO: $0.34 Normalized FFO: $0.35 AFFO: $0.36 Normalized AFFO: $0.37 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.94x Senior Housing - Leased: 1.37x Behavioral Health, Specialty Hospitals and Other: 3.68x Same store managed senior housing Cash NOI increased 17.8% on a year-over-year basis. As previously announced, in the third quarter of 2024, Sabra close
Sabra Health Care REIT, Inc. ("Sabra") (NASDAQ:SBRA) announced today that Moody's Ratings ("Moody's") issued a report on October 17, 2024 affirming Sabra's Ba1 ratings and upgrading Sabra's outlook to "Positive" from "Stable". The report credits Sabra's upgraded outlook to improving industry fundamentals for skilled nursing and senior housing, which is driving an improvement in Sabra's key credit metrics, particularly net debt to EBITDA. For additional information, Moody's Ratings report can be found on its website at www.moodys.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2024 third quarter earnings release on October 31, 2024, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 third quarter results will be held on Friday, November 1 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/444925126. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corporat
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Darrin Smith, the company's Executive Vice President of Investments, Eliza Gozar, the company's Senior Vice President of Investments, and Lauren Nisley, the company's Director of Investments, will attend the INVEST Conference on October 7-9, 2024 at the JW Marriott Dallas Arts District in Dallas, Texas. Talya Nevo-Hacohen, the company's Chief Investment Officer, and other members of the company, will attend the AHCA/NCAL 75th Annual Convention & Expo on October 7-8, 2024, at the Orange County Convention Center in Orlando, Florida. Ms. Nevo-Hacohen will participate i
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that Talya Nevo-Hacohen, the company's Chief Investment Officer, Darrin Smith, the company's Executive Vice President of Investments, Eliza Gozar, the company's Senior Vice President of Investments, and other members of the company, will attend the 2024 NIC Fall Conference on September 23-25, 2024, at the Marriott Marquis in Washington, D.C. Additionally, Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Talya Nevo-Hacohen, and Darrin Smith, will attend the Virtual Mizuho REIT Conference on October 1-2, 2024. About Sabra Sabra Health Care REIT, Inc., a Maryland
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Talya Nevo-Hacohen, the company's Chief Investment Officer, Darrin Smith, the company's Executive Vice President of Investments, and Lukas Hartwich, the company's Senior Vice President of Finance, will participate in the BofA Securities 2024 Global Real Estate Conference on September 10, 2024, at the Bank of America Tower in New York, New York. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through it
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the second quarter of 2024. SECOND QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the second quarter of 2024 were as follows: Net Income: $0.10 FFO: $0.35 Normalized FFO: $0.35 AFFO: $0.36 Normalized AFFO: $0.36 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.85x Senior Housing - Leased: 1.35x Behavioral Health, Specialty Hospitals and Other: 3.69x Same store managed senior housing Cash NOI increased 17.7% on a year-over-year basis. Investment activity through June 30, 2024 amounts
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today released its fourth annual Sustainability Report for the fiscal year 2023. The report showcases our programs, policies and initiatives that support our ESG priorities of environmental stewardship; diversity, equity and inclusion; human capital management; protection of health, wellness and safety of our teammates; engagement and collaboration with our operators and tenants; cybersecurity; corporate governance; and community service. These principles are intrinsically tied to our objective to drive shareholder value by operating efficiently, sustainably and with our stakeholders'—investors, tenants, teammates
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2024 second quarter earnings release on August 7, 2024, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 second quarter results will be held on Thursday, August 8 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/150203568. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corp
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the third quarter of 2024. THIRD QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the third quarter of 2024 were as follows: Net Income: $0.13 FFO: $0.34 Normalized FFO: $0.35 AFFO: $0.36 Normalized AFFO: $0.37 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.94x Senior Housing - Leased: 1.37x Behavioral Health, Specialty Hospitals and Other: 3.68x Same store managed senior housing Cash NOI increased 17.8% on a year-over-year basis. As previously announced, in the third quarter of 2024, Sabra close
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2024 third quarter earnings release on October 31, 2024, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 third quarter results will be held on Friday, November 1 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/444925126. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corporat
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the second quarter of 2024. SECOND QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the second quarter of 2024 were as follows: Net Income: $0.10 FFO: $0.35 Normalized FFO: $0.35 AFFO: $0.36 Normalized AFFO: $0.36 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.85x Senior Housing - Leased: 1.35x Behavioral Health, Specialty Hospitals and Other: 3.69x Same store managed senior housing Cash NOI increased 17.7% on a year-over-year basis. Investment activity through June 30, 2024 amounts
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2024 second quarter earnings release on August 7, 2024, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 second quarter results will be held on Thursday, August 8 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/150203568. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corp
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the first quarter of 2024. FIRST QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2024 were as follows: Net Income: $0.11 FFO: $0.32 Normalized FFO: $0.34 AFFO: $0.35 Normalized AFFO: $0.35 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.79x (1.79x excluding Provider Relief Funds) Senior Housing - Leased: 1.33x Behavioral Health, Specialty Hospitals and Other: 3.77x On May 8, 2024, Sabra's Board of Directors declared a quarterly cash dividend of $0.30 per share of commo
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2024 first quarter earnings release on May 8, 2024, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 first quarter results will be held on Thursday, May 9 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/588244325. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation,
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the fourth quarter of 2023. FOURTH QUARTER 2023 RESULTS AND RECENT EVENTS Results per diluted common share for the fourth quarter of 2023 were as follows: Net Income: $0.07 FFO: $0.30 Normalized FFO: $0.32 AFFO: $0.32 Normalized AFFO: $0.33 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.78x (1.72x excluding Provider Relief Funds) Senior Housing - Leased: 1.28x Behavioral Health: 1.85x Specialty Hospitals & Other: 7.00x During the fourth quarter of 2023, Sabra expanded its relationship with Ignite Medical Resorts
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2023 fourth quarter earnings release on February 27, 2024, after the close of trading. A conference call with a simultaneous webcast to discuss the 2023 fourth quarter results will be held on Wednesday, February 28 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-596-4144. For participants outside the U.S., the dial-in number is 646-968-2525. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/290282806. A digital replay of the call will be available on our website at www.sabrahealth.com. Also, on February 1, 2024, Sabra's board of director
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today the tax treatment for its 2023 distributions. The following table summarizes, for income tax purposes, the nature of cash distributions paid: Sabra Health Care REIT, Inc. Common Stock (CUSIP # 78573L106) Record Date Payable Date Distribution per Share Total Ordinary Dividends Non- Qualified Dividends Qualified Dividends Non- Dividend Distributions 02/13/2023 02/28/2023 $ 0.3000000 $ 0.1709313 $ 0.1709313 $ 0.0000000 $ 0.1290687 05/16/2023 05/31/2023 0.3000000
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the third quarter of 2023. THIRD QUARTER 2023 RESULTS AND RECENT EVENTS Results per diluted common share for the third quarter of 2023 were as follows: Net Loss: $(0.07) FFO: $0.33 Normalized FFO: $0.33 AFFO: $0.35 Normalized AFFO: $0.34 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.68x (1.61x excluding Provider Relief Funds) Senior Housing - Leased: 1.17x Behavioral Health: 1.92x Specialty Hospitals & Other: 6.72x During the third quarter of 2023, Sabra generated $80 million of gross proceeds from the dispositi
Sabra Health Care REIT, Inc. ("Sabra") (NASDAQ:SBRA) today announced that Jessica Flores has been appointed Executive Vice President and Chief Accounting Officer and, in such capacity, has been designated by the Company's Board of Directors as the Company's principal accounting officer. Ms. Flores currently serves as Sabra's Senior Vice President – Finance and Controller, a position she has held since January 2022. Ms. Flores joined Sabra in March 2011 and held various leadership positions overseeing Sabra's accounting during that time. Ms. Flores has over 15 years of experience in accounting, finance and real estate investments, having previously worked for KBS Realty Advisors and Deloit
IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced the appointment of Katie Cusack to its Board of Directors. Ms. Cusack currently serves as Chief Operating Officer of Cornell Capital LLC, a $4 billion private investment firm with offices in New York and Hong Kong. From 2007 to 2020, Ms. Cusack served in various capacities at Credit Suisse, including Chief Operating Officer for the Investment Banking Division in both Asia Pacific and Europe, Middle East and Africa, and as the Head of Ultra-High Net Worth Coverage. Prior to joining Credit Suisse, Ms. Cusack served as a Managing Director at MTS Health Partners LP, where she provided
IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced the appointment of Ann Kono to its Board of Directors. Ms. Kono currently serves as the chief executive officer of Leda Advisory Group, a management consulting firm she founded in January 2019 that partners with startup companies to advise on growth and scale. Prior to founding Leda, Ms. Kono spent 11 years at Ares Management Corporation, where she held the position of Chief Information and Risk Officer, and oversaw Operational, Investment and Enterprise Risks. Ms. Kono also serves on the board of directors of Stable Road Acquisition Company, a position she has held since 2019. M
IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced the appointment of Clifton J. Porter II to its Board of Directors. Clifton J. Porter II currently serves as Senior Vice President of the American Healthcare Association/National Center for Assisted Living and is responsible for leading and executing the Association’s policy and legislative agenda impacting both the skilled nursing and assisted living sectors. Mr. Porter has over 31 years of experience in the long-term care profession, starting in operations as an Administrator in Training in 1989 ultimately leading to the oversight of multiple facilities in a large urban market. I
SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)
SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)
SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)
SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)
SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)
SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)
SC 13G - Sabra Health Care REIT, Inc. (0001492298) (Subject)
SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)
SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)
SC 13G - Sabra Health Care REIT, Inc. (0001492298) (Subject)
Truist downgraded Sabra Health Care REIT from Buy to Hold
JMP Securities upgraded Sabra Health Care REIT from Mkt Perform to Mkt Outperform and set a new price target of $20.00
Mizuho downgraded Sabra Health Care REIT from Outperform to Neutral and set a new price target of $20.00
Wells Fargo upgraded Sabra Health Care REIT from Equal Weight to Overweight and set a new price target of $20.00 from $16.00 previously
Citigroup upgraded Sabra Health Care REIT from Neutral to Buy and set a new price target of $20.00 from $17.00 previously
Deutsche Bank initiated coverage of Sabra Health Care REIT with a rating of Buy and set a new price target of $21.00
BMO Capital Markets downgraded Sabra Health Care REIT from Outperform to Market Perform and set a new price target of $16.00
Wells Fargo upgraded Sabra Health Care REIT from Underweight to Equal Weight and set a new price target of $15.00 from $13.00 previously
BofA Securities upgraded Sabra Health Care REIT from Neutral to Buy and set a new price target of $16.00 from $14.00 previously
Wedbush initiated coverage of Sabra Health Care REIT with a rating of Outperform and set a new price target of $16.00